PayerPrice
Data Platform
Sign InCheck Local Rates

HCPCS Q2057 (Tecelra) Fee Schedule

Last Verified: July 2026

Healthcare providers use this code to document and receive reimbursement for visits that address high-level medical decision-making, often including multiple diagnoses or prescription management.

Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose
Key FactDetail
Service Type

Temporary Codes

Other Drugs and Service Fees

Complexity LevelHigh
Medicare Payment Limit
$770620BuyandBill.com
WAC Price
Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur

National average reimbursement for HCPCS Q2057 by major payers:

bcbs

$717,240.85

uhc

$690,650.00

aetna

$924,745.00

cigna

$N/A

Preview provider-level rates for...
For billing codeHCPCS Q2057
PayerCodeRateNPITax IDStateSpecialty

No data found

No fee schedule data available for the selected payer and code combination

Want to see your competitors' rates?

Start your trial today to unlock complete access to provider rates and fee schedules in your area.

Here's what you can do with PayerPrice

Renegotiate your managed care contracts

Benchmark your current rates against market averages to identify opportunities for rate optimization.

Prospect for new business using fee schedules

Access every provider's negotiated rates for every billing code in your market to inform your prospecting strategies.

Integrate real-time payer data into your workflows

Automatically keep fee schedules up-to-date without adding yet another log-in to your insurance systems. Connect via API or SQL.

PayerPrice shows you the exact negotiated rates that insurers publish under federal transparency rules.
We display the raw data directly from insurers' files, giving you the same information they make public. Learn more about Price Transparency.

HCPCS Q2057 vs. Other Other Drugs and Service Fees Codes

The HCPCS Q2057 code is part of the Temporary Codes services used for Other Drugs and Service Fees. It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS Q2057 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

CodeComplexityDescription
Q2057-HCPCSHighAfamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS Q2057. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the Q2057 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

FREE SAMPLE MARKET COMPARISON

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS Q2057) and we'll show you how you compare in 15 minutes or less.